Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 19.0B | 27.9B | 18.9B | 18.4B |
Cost of revenue | 12.3B | 20.2B | 13.3B | 13.0B |
Gross profit | 6.7B | 7.7B | 5.6B | 5.4B |
Operating expense | ||||
Research & development | 799.3M | 787.3M | 890.0M | 830.0M |
Selling general and admin | 1.3B | -1.3B | 2.5B | -299.0M |
Other operating expenses | 116.0M | 159.9M | 102.3M | 102.1M |
Operating income | 4.6B | 5.5B | 3.4B | 3.7B |
Non operating interest income | ||||
Income | 89.1M | 63.2M | 62.4M | 57.7M |
Expense | 77.2M | 81.3M | 119.2M | 107.5M |
Other income expense | — | — | — | — |
Pretax income | 4.6B | 4.5B | 3.1B | 3.5B |
Tax provision | 769.5M | 979.4M | 398.8M | 514.9M |
Net income | 3.8B | 3.5B | 2.7B | 2.9B |
Basic EPS | 1.9 | — | — | — |
Diluted EPS | 1.9 | — | — | — |
Basic average shares | 2.1B | — | — | — |
Diluted average shares | 2.1B | — | — | — |
EBITDA | 4.9B | 5.7B | 3.5B | 3.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | 32.8M | -101.5M | -38.9M | -76.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |